Sign in

CIK 0001061983

  • Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
943291317
Phone
+1 650-624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Planned sale EVP Research & Development sold 3,500 shares at $75.46 ($264,110)
  2. 4 Planned sale Director sold 5,000 shares at $71.48 ($357,400)
  3. 4 Planned sale EVP, Chief Commercial Officer sold 10,000 shares at $70.24 ($702,400)
  4. 4 Planned sale President & CEO sold 7,500 shares at $70.24 ($526,800)
  5. 4 Planned sale EVP Research & Development sold 3,500 shares at $75.82 ($265,370)
  6. 4 Planned sale President & CEO sold 7,500 shares at $76.76 ($575,700)
  7. 4 Planned sale EVP, Chief Commercial Officer sold 14,000 shares at $79.88 ($1,118,320)
  8. 4 Planned sale President & CEO sold 7,500 shares at $80.87 ($606,525)
  9. 4 Planned sale EVP Research & Development sold 3,500 shares at $80.59 ($282,065)
  10. 4 Grant or award Director acquired 75 shares (grant or award)
  11. 4 Grant or award Director acquired 75 shares (grant or award)
  12. 4 Grant or award Director acquired 151 shares (grant or award)
  13. 4 Grant or award Director acquired 272 shares (grant or award)
  14. 4 Grant or award Director acquired 151 shares (grant or award)
  15. 4 Grant or award Director acquired 151 shares (grant or award)
  16. 4 Planned sale President & CEO sold 7,500 shares at $82.02 ($615,150)
  17. 4 Planned sale EVP Research & Development sold 3,500 shares at $86.62 ($303,170)
  18. 4 Planned sale President & CEO sold 7,500 shares at $84.92 ($636,900)
  19. 4 Planned sale EVP, Chief Commercial Officer sold 15,000 shares at $85.80 ($1,287,000)
  20. 4 Planned sale EVP, Chief Financial Officer sold 1,112 shares at $87.79 ($97,622)

Page 2 of 70 · 1,399 filings